2026 Spring Call
Funds innovative research on genetic intellectual disabilities (excluding Down syndrome), supporting studies from basic science to clinical applications while requiring strict bioethical compliance.
Funder: Jerome Lejeune Foundation
Due Dates (Anticipated): February 2027 (full application deadline, projected)
Funding Amounts: Pilot: up to €50,000 over 2 years | Advanced: up to €80,000 over 2 years
Summary: Supports innovative research on genetic intellectual disabilities (excluding Trisomy 21), spanning fundamental, translational, clinical, epidemiological, and neuropsychological studies.
Key Information: Strict bioethics policy: no use of human embryonic/fetal tissues, IVF, or cloning-derived materials.
Description
This program funds research projects that advance the understanding, diagnosis, or treatment of intellectual disabilities of genetic origin, except Trisomy 21 (Down syndrome). Supported research areas include fundamental studies on disease mechanisms, translational projects with potential patient impact, clinical research (including early-phase studies and ancillary trials), epidemiological investigations, and neuropsychology or methodological innovation. The grant aims to foster both early-stage (pilot) and advanced projects, with a strong emphasis on scientific excellence, innovation, and potential clinical relevance. Proposals must adhere to strict ethical standards, specifically excluding the use of human embryonic or fetal tissues, IVF, or cloning-derived materials.
